8-K
filed May 22, 2023, 7:59 PM ET
ticker LONA
CIK 0001620463
leadership
confidence high
sentiment neutral
materiality 0.70
Athira Pharma appoints Andrew Gengos as CFO and CBO; Glenna Mileson retires
LeonaBio, Inc.
- Andrew Gengos appointed CFO and CBO effective May 18, 2023, replacing Glenna Mileson who is retiring after eight years.
- Gengos receives $465,000 base salary, 40% bonus target, 400,000 stock options, and 10,000 RSUs tied to LIFT trial milestones.
- Mileson will remain as transitional employee until June 16, 2023, then may serve as consultant at $3,500/month for up to 10 hours.
- Stockholders elected Class III directors Kelly Romano and James Johnson; ratified Ernst & Young as auditor.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Glenna Mileson resigned as Chief Financial Officer at LeonaBio, Inc..
- Action
- resigned
- Role
- Chief Financial Officer
Exact text from the filing
Glenna Mileson, the Company’s Chief Financial Officer, resigned from her position as Chief Financial Officer on May 18, 2023 effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Andrew Gengos was appointed as Chief Financial Officer and Chief Business Officer at LeonaBio, Inc..
- Action
- appointed
- Role
- Chief Financial Officer and Chief Business Officer
Exact text from the filing
the Company’s board of directors (the “Board”) appointed Andrew Gengos as the Company’s Chief Financial Officer and Chief Business Officer, effective May 18, 2023.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
LeonaBio, Inc. shareholders approved Election of Class III Directors at the 2023-05-18 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-05-18
Exact text from the filing
Proposal No. 1 – Election of Class III Directors The stockholders elected the two candidates nominated by the Company’s Board of Directors (the “Board”) to serve as directors of the Company until the annual meeting of stockholders to be held in 2026 or until their successors are elected and qualified. The following sets forth the results of the voting with respect to each candidate: Nominees of the Board For Withhold Broker Non-Votes Kelly A. Romano 13,993,414 3,466,402 9,303,812 James A. Johnson 14,519,313 2,940,503 9,303,812
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
LeonaBio, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-05-18 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-05-18
Exact text from the filing
Proposal No. 2 – Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2023. The following sets forth the results of the voting with respect to this proposal: For Against Abstain Broker Non-Votes 26,704,561 39,131 19,936 0
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.